Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 5
1987 8
1988 18
1989 17
1990 24
1991 24
1992 28
1993 28
1994 38
1995 36
1996 37
1997 41
1998 37
1999 52
2000 58
2001 62
2002 81
2003 89
2004 92
2005 89
2006 87
2007 69
2008 56
2009 65
2010 54
2011 56
2012 34
2013 64
2014 65
2015 52
2016 56
2017 64
2018 53
2019 55
2020 73
2021 58
2022 52
2023 53
2024 68
2025 69
2026 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,937 results

Results by year

Filters applied: . Clear all
Page 1
Loratadine.
AlMasoud N, Bakheit AH, Alshammari MFM, Abdel-Aziz HA, AlRabiah H. AlMasoud N, et al. Profiles Drug Subst Excip Relat Methodol. 2022;47:55-90. doi: 10.1016/bs.podrm.2021.10.002. Epub 2021 Dec 7. Profiles Drug Subst Excip Relat Methodol. 2022. PMID: 35396016 Review.
Loratadine, 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester, is an antihistamine drug with long-acting effects and has limited selectivity for peripheral H1 receptors. ...This chapter discusses, by a critic …
Loratadine, 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester, is an …
Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial.
Yamprasert R, Chanvimalueng W, Mukkasombut N, Itharat A. Yamprasert R, et al. BMC Complement Med Ther. 2020 Apr 20;20(1):119. doi: 10.1186/s12906-020-2875-z. BMC Complement Med Ther. 2020. PMID: 32312261 Free PMC article. Clinical Trial.
This study was designed to assess efficacy and safety of ginger extract in comparison with loratadine for AR treatment. METHODS: AR patients were treated with ginger extract 500 mg (n = 40) against those treated with loratadine 10 mg (n = 40) in a randomized, double …
This study was designed to assess efficacy and safety of ginger extract in comparison with loratadine for AR treatment. METHODS: AR p …
Desloratadine.
McClellan K, Jarvis B. McClellan K, et al. Drugs. 2001;61(6):789-96; discussion 797. doi: 10.2165/00003495-200161060-00007. Drugs. 2001. PMID: 11398910
Desloratadine is the orally active major metabolite of the nonsedating H1-antihistamine loratadine. The drug had no adverse cardiovascular effects in various animal models or when administered at 9 times the recommended adult dosage for 10 days in volunteers. ...
Desloratadine is the orally active major metabolite of the nonsedating H1-antihistamine loratadine. The drug had no adverse cardiovas …
EDITORIAL.
Kennedy DW. Kennedy DW. Int Forum Allergy Rhinol. 2015 Dec;5(12):1083-4. doi: 10.1002/alr.21692. Int Forum Allergy Rhinol. 2015. PMID: 26769189 No abstract available.
Shiitake dermatitis.
Bachmeyer C, Rouff E. Bachmeyer C, et al. CMAJ. 2017 Mar 20;189(11):E439. doi: 10.1503/cmaj.160644. CMAJ. 2017. PMID: 28385716 Free PMC article. No abstract available.
Desloratadine (Clarinex).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2002 Mar 18;44(1126):27-8. Med Lett Drugs Ther. 2002. PMID: 11941265 No abstract available.
Loratadine toxicity.
Gokel Y, Satar S, Sebe A. Gokel Y, et al. Am J Emerg Med. 2000 Sep;18(5):639-40. doi: 10.1016/s0735-6757(00)90110-4. Am J Emerg Med. 2000. PMID: 10999590 No abstract available.
Loratadine augments emotional blushing.
Drummond PD, Lester B. Drummond PD, et al. Eur Neuropsychopharmacol. 2018 Nov;28(11):1284-1288. doi: 10.1016/j.euroneuro.2018.08.003. Epub 2018 Aug 26. Eur Neuropsychopharmacol. 2018. PMID: 30153954 Clinical Trial.
The aim of this study was to determine whether loratadine, a selective inverse agonist of peripheral histamine H(1) receptors, would reduce emotional blushing. ...Increases in facial blood flow while participants sang were greater in the loratadine than the placebo …
The aim of this study was to determine whether loratadine, a selective inverse agonist of peripheral histamine H(1) receptors, would …
Desloratadine: a nonsedating antihistamine.
Limon L, Kockler DR. Limon L, et al. Ann Pharmacother. 2003 Feb;37(2):237-46; quiz 313-6. doi: 10.1177/106002800303700216. Ann Pharmacother. 2003. PMID: 12549956 Review.
Cardiovascular profile of loratadine.
Hey JA, Affrime M, Cobert B, Kreutner W, Cuss FM. Hey JA, et al. Clin Exp Allergy. 1999 Jul;29 Suppl 3:197-9. doi: 10.1046/j.1365-2222.1999.0290s3197.x. Clin Exp Allergy. 1999. PMID: 10444237 Review.
The extremely low reporting rate of cardiovascular adverse events for loratadine, the possible preferential use of loratadine in patients with pre-existing cardiovascular disorders, and the impressive lack of cardiovascular effects at extremely high concentrations i …
The extremely low reporting rate of cardiovascular adverse events for loratadine, the possible preferential use of loratadine …
1,937 results